AAPS Presents Workshop on Dissolution

ARLINGTON, Va. - The American Association of Pharmaceutical Scientists (AAPS) will present the AAPS Workshop on Dissolution: Current and Emerging Practices - Methodology, Technology and Regulatory Issues, May 7-8 at the Crystal Gateway Marriott in Arlington, Va.

Dissolution testing plays a critical role in several major phases of a pharmaceutical's life cycle. Dissolution is used to evaluate new formulations, to examine the stability of dosage forms, and as a measure in the quality assurance/quality control areas. Dissolution can also be used as a replacement for some in-vivo studies in the Food and Drug Administration’s Abbreviated New Drug Application process. The workshop will explore the current issues surrounding dissolution testing and examine the most important changes in the field.

This workshop, co-sponsored with United States Pharmacopeia (USP), will focus on three major areas. The Calibration session will address the current issues from industry, usp and fda perspectives. The Biopharmaceutical Classification System session will examine the intent and extent of the changes to the drug approval process from industry and fda perspectives. The New and Non-Traditional Methodologies and Technologies session will present a number of methods, techniques and technologies that may become integral to the future of dissolution testing. The New and Non-Traditional Methodologies and Technologies session will also examine several new and exciting dose forms that have presented unique challenges to traditional dissolution testing.

Participants will have an opportunity to meet with suppliers, including AC Compacting LLC, Delphian Technology L.P., Erweka USA, Inc., LEAP Technologies, Sotax Corp., and VanKel Technology Group. Additional information on the AAPS Workshop on Dissolution can be found on AAPS Pharmaceutica at www.aapspharmaceutica.com/dissolution.

About AAPS
AAPS is a professional, scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Pharmaceutica at www.aapspharmaceutica.com.

* * *